Found 858 results
By Sean Brodrick On May 23, 202201:12 PM Eastern
Cybercrime is exploding. Its global cost is expected to eclipse $10.5 trillion per year by 2025, ballooning from $6 trillion in 2021 and $3 trillion 10 years ago!
By Beth Canova On April 12, 202204:00 PM Eastern
And it’s not the only centralized government getting in on the craze.
By Jessica Borg On January 30, 202209:30 AM Eastern
It’s one of the hottest trends in investing … and it’s only in its infancy. I’m talking about metaverse mania! And it’s not just a popular buzzword … it’s a burgeoning market with real investment oppo
By Kelly Green On December 30, 202107:00 AM Eastern
The “Yankee Candle indicator” sent me running to the Weiss Ratings, where I sniffed out a great stock idea.
By Jon D. Markman On December 15, 202103:00 PM Eastern
Digital ad spending has become the epicenter of advertising, and as more companies commit to digital ad strategies, this business will continue to thrive.
By Jon D. Markman On December 10, 202103:00 PM Eastern
Tech stocks are out of favor again. To me this means one thing: yet another possible great opportunity for long-term investors considering a platform that could be responsible for their very own futur
By Jon D. Markman On November 17, 202103:00 PM Eastern
Wearing tech hardware to access an alternative digital reality may seem silly and unnecessary, yet it’s going to be a huge new investment opportunity.
By Jurica Dujmovic On November 11, 202105:50 PM Eastern
Yet another week in crypto is behind us, and what a week it was! Plenty of things going on in the industry, as well as on the fringes. Let’s start on the outside and work our way in. First,...
By Kelly Green On November 11, 202107:00 AM Eastern
I’m not a big advocate for exchange-traded funds (ETFs). I like to research individual stocks and handpick my personal portfolio. But just like any other tool in your investor toolbox, there is a time
By Jon D. Markman On November 8, 202102:39 PM Eastern
On Friday, executives at Alphabet (Nasdaq: GOOGL) announced that the company is setting up Isomorphic Labs, a commercial venture that will use artificial intelligence (AI) to develop drug therapies.